Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19).

Arachchillage, Deepa R J; Shi, Christine; Saliu, David; Kozman, Peter; Mi, Emma; Buti, Noora; Kashef, Elika; Copley, Susan J; Gomez, Carlos; Leonard, Richard; Aziz, Riaz; Shlebak, Abdul A; Laffan, Mike

Arachchillage, Deepa R J; Shi, Christine; Saliu, David; Kozman, Peter; Mi, Emma; Buti, Noora; Kashef, Elika; Copley, Susan J; Gomez, Carlos; Leonard, Richard; Aziz, Riaz; Shlebak, Abdul A; Laffan, Mike.

Arachchillage DRJ; Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Shi C; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
Saliu D; Department of Haematology, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom.
Kozman P; Department of Emergency Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom.
Mi E; Department of Emergency Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom.
Buti N; Department of Emergency Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom.
Kashef E; Department of Emergency Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom.
Copley SJ; Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Gomez C; Department of Radiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Leonard R; Department of Radiology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Aziz R; Department of Intensive Care and Anaesthesia, Imperial College Healthcare NHS Trust, London, United Kingdom.
Shlebak AA; Department of Intensive Care and Anaesthesia, Imperial College Healthcare NHS Trust, London, United Kingdom.
Laffan M; Department of Intensive Care and Anaesthesia, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom.

Semin Thromb Hemost ; 47(4): 436-441, 2021 06.

Article in English | MEDLINE | ID: covidwho-1041020

Subject(s)

Anticoagulants/therapeutic use; COVID-19/blood; Enoxaparin/therapeutic use; Fibrin Fibrinogen Degradation Products/analysis; Kidney/physiopathology; SARS-CoV-2; Thrombophilia/drug therapy; Thrombosis/prevention & control; Aged; Aged, 80 and over; Anticoagulants/administration & dosage; Body Weight; C-Reactive Protein/analysis; COVID-19/complications; Dose-Response Relationship, Drug; Enoxaparin/administration & dosage; Female; Guideline Adherence; Humans; Incidence; Intensive Care Units/statistics & numerical data; Male; Mean Platelet Volume; Middle Aged; Oxygen/blood; Practice Guidelines as Topic; Proportional Hazards Models; Retrospective Studies; Risk Factors; Thrombophilia/etiology; Thrombosis/epidemiology; Thrombosis/etiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / Fibrin Fibrinogen Degradation Products / Enoxaparin / Thrombophilia / SARS-CoV-2 / COVID-19 / Kidney / Anticoagulants Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Semin Thromb Hemost Year: 2021 Document Type: Article Affiliation country: S-0040-1722309

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google